Trial intelligence / Profile preview

Vonoprazan vs proton pump inhibitor regimens for Helicobacter pylori eradication

ChiCTR2300076723Phase 4Completed

Sponsor
Second Affiliated Hospital of Hainan Medical University
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of vonoprazan and ilaprazole in Helicobacter pylori infection (3 arms), sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoint: Helicobacter pylori eradication by 13C or 14C urea breath test. Started Jul 2022; status: completed.

02

Drugs

vonoprazanilaprazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on ChiCTR2300076723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call